Braxia Scientific Profit Margin

The latest profit margin for BRAXF is -436.37% as of December 2023. That compares with -710.06% in the prior-year period — up 38.5% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Braxia Scientific's historical trend and sector peers before judging valuation or financial health.

Over the past year, BRAXF's profit margin moved from -710.06% to -436.37% — a 38.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Braxia Scientific's valuation or profitability profile.

Against Healthcare companies, BRAXF currently prints -436.37% for profit margin, while the sector average sits near 10.58%. That is roughly 4224.3% below the sector mean. Large gaps often invite a closer look at Braxia Scientific's growth, margins, and balance sheet.

Profit Margin shows how effectively Braxia Scientific converts resources into returns. At -436.37%, BRAXF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -710.06% in the prior-year period — up 38.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BRAXF's profit margin (-436.37%), review year-over-year change from -710.06%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.